Luminex Partners

DESTINA offers a complete miRNA-122 profiling service combining its ChemiRNA™ Tech with the highly sensitive Luminex^® systems (MAGPIX^®, FLEXMAP 3D^®). Cell supernatants and lysates, plasma and serum samples can be prepared and delivered using DESTINA Stabiltech buffer without the need for expensive refrigerated transport. miRNA-122 can then be detected and quantified directly from these biological samples without the need for extraction, reverse transcription or amplification using standard Luminex system workflows.

• Application Area: Biomarker Screening
• Target: Nucleic Acid
• Primary Business: Kits, Testing Services
• Market Availability: Europe
• Regulatory Classification: IVD, RUO

DiaCarta creates kits and provides testing services for cancer applications.

• Application Area: Oncology
• Target: Nucleic Acid
• Primary Business: Kits, Testing Services
• Market Availability: Europe, United States
• Regulatory Classification: IVD

Eurofins Viracor has over 30 years of diagnostic innovation and specialized expertise in infectious disease, pre- and post-transplant, allergy and immunology testing for immunocompromised and critical patients, and more.

• Application Area: Allergy, Autoimmune, Infectious Disease
• Target: Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO, LDT

G&G Science Co., Ltd. is a bio-venture company that develops genetic and biomarker tests and testing services for precision medicine.

• Application Area: Biomarker Screening
• Target: Nucleic Acid
• Primary Business: Testing Services
• Market Availability: Asia-Pacific
• Regulatory Classification: RUO

The OmniPlex™-HPV 40 Genotyping kit is a multiplex liquid-bead microarray capable of identifying 40 genotypes. The NeoPlex™ STI Detection Kits are multiplex real-time PCR kits that can detect 7–14 STI-causing pathogens simultaneously with a single-tube PCR reaction.

• Application Area: Infectious Disease
• Target: Nucleic Acid
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: IVD

Genetic Analysis AS (GA) is a science-based diagnostic company and pioneer in the human microbiome field with more than 10 years of expertise in research and product development. The unique GA-map^® platform is based on a pre-targeted multiplex approach specialized for simultaneous analysis of a large number of bacteria in one reaction. The test results are generated by utilizing the clinically validated cutting-edge GA-map software algorithm, which enables immediate results without the need for further bioinformatics work. GA’s mission is to become the leading company for standardized gut microbiota testing worldwide, and they are committed to helping unlock and restore the human microbiome through its state-of-the-art technology.

• Application Area: Gastrointestinal, Infectious Disease
• Target: Nucleic Acid
• Primary Business: Kits, Testing Services
• Market Availability: Europe, United States
• Regulatory Classification: IVD, RUO

Bright-Innovation BioMed is a leader in the developing and manufacturing nucleic acid products for academic and commercial application. They have developed a deafness gene assay kit based on Luminex xMAP^® Technology for multiplex detection of high frequency hearing-related gene mutations in GJB2, GJB3, SLC26A4, and mtDNA 12S rRNA, which cover the most common deafness gene mutations in Chinese population.

• Application Area: Hereditary Diseases
• Target: Nucleic Acid
• Primary Business: Kits
• Market Availability: Asia-Pacific
• Regulatory Classification: IVD

Detect infectious disease pathogens from samples that originate from commercial food production and farming. These kits are for use in animal health and food safety testing in China.

• Application Area: Food Safety / Production Animal
• Target: Nucleic Acid, Protein
• Primary Business: Kits
• Market Availability: Asia-Pacific

Whatever your laboratory diagnostic or animal health monitoring needs, IDEXX stands ready with world-class expertise. Their scientific team has developed nearly all the newest technologies in the industry, including the innovative Opti-Spot^® blood collection process that uses just a simple drop of whole blood for comprehensive serology testing, and their Advantage Program that provides results in 3 business days.

• Application Area: Biomarker Screening, Companion Animal Testing, Laboratory Animal Testing
• Target: Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

ImmunoProfile^®'s goal is to empower people everywhere to protect themselves from infectious diseases. They do this by providing a simple and easy way to evaluate your antibody status through a Test Kit that covers 11 major vaccine checks all in one. Using a home collection kit, customers can access their results through a secure and private online portal.

• Application Area: Immune Response Screening
• Target: Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO, LDT